Wednesday, 28 September, 2022
TopicVaccine

Topic: Vaccine

India vaccine against cervical cancer to be launched Thursday, ‘will combat global shortage’

The Serum Institute of India & Department of Biotechnology are set to launch the country's first indigenously developed Quadrivalent Human Papillomavirus vaccine against cervical cancer.

After Covid, mRNA vaccine for cancer? US researchers report initial success against melanoma

Mice treated with the mRNA vaccine, delivered like ones for Covid, showed reduction in tumours & long-term immune memory, says study by Tufts University researchers published in PNAS.

How ICAR grew 50 generations of virus over 1.5 years to develop lumpy skin disease vaccine

Lumpi-ProVac, a vaccine developed by 2 Indian Council of Agricultural Research institutes, was found effective in preventing lumpy skin disease in cattle & is ready for commercial launch.

Covaxin safe for kids, generates higher antibody response in them than adults, says Lancet paper

The results of the phase ⅔ clinical trials of the indigenous Covid vaccine have been peer-reviewed and published in the The Lancet Infectious Diseases journal.

Celebrities can’t use ‘my body, my choice’ to oppose Covid vaccine. They aren’t special

Morality is not limited to just not causing harm. For better or worse, many people look up to celebrities as people to admire and emulate.

Modi, Rahul Gandhi, and Djokovic — what liberals miss

The Djokovic episode is a real-life dilemma of moral philosophy that will be cited as a case study for future philosophy courses.

Omicron shows why global vaccine chains should be ready for unforeseen shocks

As Covid pandemic moves to epidemic conditions with regional hotspots, caution must be taken because any fault line in global vaccine supply can be cataclysmic.

India makes progress in child vaccination against diarrhoea, pneumonia amid Covid, report says

According to the IVAC report, India’s coverage of pneumococcal conjugate vaccine, increased by 6 percentage points while rotavirus vaccine for diarrhoea, rose by 29 percentage points.

Covid travel can be an opportunity, not just a risk

There are emotional and economic costs to restricting travel. No relaxation of curbs is risk-free, but it has to be balanced against the progress made in managing Covid.

Bharat Biotech’s Ankleshwar plant, manufacturer of rabies vaccine, rolls out 1st batch of Covaxin

Health Minister Mansukh Mandaviya released the first commercial batch of Covaxin from the Gujarat plant Sunday, said it had the capacity to produce more than 1 crore doses per month.

On Camera

YourTurn

The logo of the Adani Group is seen on the facade of one of its buildings on the outskirts of Ahmedabad | Reuters file photo

From ports to energy transition — Adani Group to invest over $100 billion in next decade

Speaking at Forbes Global CEO Conference in Singapore, Adani said the group intends to do more as a solar player & has earmarked 70% of the investment for the energy transition space.

Defence

Parts of Iranian made 'suicide' drone Shahed-136 after being shot down by the Ukrainian military | Reuters

All about Shahed-136, Iran’s ‘kamikaze’ drone that Russia is using to strike Ukraine

Over the past few days, Russia has hit multiple targets using these Iranian-supplied drones—including civilian structures and amenities—leading to the death of several Ukrainians.
Illustration by Soham Sen | ThePrint

AAP’s filling a big vacuum in Indian politics. Question is how long it can sustain without ideology

If you find admiration for AAP qualified, if not muted among many of the Modi-BJP’s critics, it is because they question it for its lack of ideological clarity. Especially on secularism.
×